LEEF Brands reported third-quarter 2026 revenue of $8.1 million and net income of $281,941, with income tax expense collapsing to $56,013 after the company concluded 280E no longer applies to its qualifying medical sales.

The Quarter
LEEF Brands, the California cannabis operator, reported its third-quarter 2026 results on November 17, 2026.
Revenue for the quarter was $8.1 million, compared with $8.4 million during the same period last year, a 4% decrease. The company posted net income of $281,941, compared with a $3.8 million loss a year earlier, and gross margin improved to 38.2% from 37.4%.
The Tax Line
LEEF reported $56,013 in income tax expense for the quarter, down from $1,038,063 in the third quarter of 2025 — a drop of roughly 95%.
Section 280E of the Internal Revenue Code generally prohibits businesses trafficking in Schedule I or II controlled substances from deducting ordinary business expenses, apart from cost-of-goods-sold treatment.
LEEF attributed the change in its tax position to federal rescheduling. The company said it concluded that Section 280E no longer applies to its qualifying medical cannabis sales beginning July 1, 2026. Its filing notes that adult-use cannabis remains Schedule I, so the tax treatment of the two kinds of sales is not the same.
Sources
- LEEF Brands Q3 2026 results, November 17, 2026
- The Marijuana Herald, November 17, 2026
Read next
USPS Says Medical Marijuana Is Nonmailable 'Under Any Circumstances' — One Day After Georgia's First Shipmentsarticles · Nov 18, 2026
Georgia Companies Launch Medical Cannabis Shipping Program, Claim U.S. Firstarticles · Nov 17, 2026
Hemp Guardrails Act: Senators File 1% THC Plan Before December 11 Banarticles · Nov 17, 2026
California License Split: DCC Files Emergency Readoption to Beat the December 2 Expiryarticles · Nov 17, 2026
1. LEEF Brands. Third-quarter 2026 results, November 17, 2026.
2. The Marijuana Herald. November 17, 2026. Report on LEEF's results and tax position.
0 comments